Asarfi Hospital shareholders approve NSE listing, BSE migration at AGM
- Shareholders approved migration to BSE Main Board and NSE listing with 100% assent
- Total valid votes cast stood at 13,354,160 across all three resolutions
- Re-appointment of Mr. Gopal Singh as Director was also approved unanimously

*this image is generated using AI for illustrative purposes only.
Asarfi Hospital Limited shareholders approved the company’s migration from the BSE SME Platform to the BSE Main Board and its listing on the National Stock Exchange of India Limited during its 21st Annual General Meeting.
The meeting was held on September 18, 2026, at the company’s registered office in Dhanbad, Jharkhand. Dr. Sukanti Kumar Das chaired the proceedings, which commenced at 12:00 pm and concluded at 2:00 pm.
Key Resolutions Passed
Shareholders approved three ordinary resolutions during the AGM:
- Adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.
- Re-appointment of Mr. Gopal Singh as Director, who retires by rotation and offered himself for re-election.
- Migration from the BSE SME Platform to the BSE Main Board and listing of equity shares on the National Stock Exchange of India Limited.
Attendance and Participation
A total of 16 members and six proxy or authorized representatives attended the physical meeting. The quorum was confirmed before the proceedings began.
The following directors and key managerial personnel were present:
| Name | Designation | Status |
|---|---|---|
| Udai Pratap Singh | Managing Director | Present |
| Madhuri Singh | Executive Director | Present |
| Dr. Sukanti Kumar Das | Non-Executive Director | Present |
| Gopal Singh | Director | Present |
| Rajkumari Sharma | Independent Director | Present |
| Harendra Singh | Chief Financial Officer | Present |
| Sudipa Singh | Company Secretary & Compliance Officer | Present |
Independent Director Amit Kumar Barnwal was absent from the meeting.
Voting Process
The company facilitated remote e-voting through NSDL from September 15, 2026, at 10:00 am to September 17, 2026, at 5:00 pm. CS Sourav Mall (Membership No. A67274) was appointed as the scrutinizer to oversee the voting process for both remote e-voting and physical voting at the AGM.
The Chairman addressed the members regarding future plans and growth projections, inviting queries from attendees. The statutory registers and other documents were available for inspection during the meeting.
Voting Results Details
The scrutinizer’s report dated September 19, 2026, confirmed that all three resolutions were passed with a requisite majority. The consolidated voting results indicate 100% assent for each resolution, with zero dissenting votes recorded across all shareholder categories.
The total number of valid votes cast was 13,354,160, representing approximately 67.87% of the total outstanding shares of 19,677,300. The breakdown of votes polled is as follows:
| Resolution Description | Votes in Favour | Votes Against | Total Valid Votes | Result |
|---|---|---|---|---|
| Adoption of Financial Statements FY26 | 13,354,160 | 0 | 13,354,160 | Passed |
| Re-appointment of Mr. Gopal Singh | 13,354,160 | 0 | 13,354,160 | Passed |
| Migration to BSE Main Board & NSE Listing | 13,354,160 | 0 | 13,354,160 | Passed |
The report noted that votes were cast through both remote e-voting and Insta Poll at the venue. Remote e-voting accounted for 11,709,140 votes, while 1,645,020 votes were cast via Insta Poll during the meeting. No invalid votes or abstentions were reported in the final tally.
Historical Stock Returns for Asarfi Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.05% | +12.97% | +8.79% | +3.98% | +54.16% | +92.74% |
What is the expected timeline for the regulatory approvals and final listing on the NSE and BSE Main Board?
How does the migration to the Main Board align with Asarfi Hospital's capital expenditure plans for new healthcare facilities?
What impact is the broader investor base from the Main Board expected to have on the company's liquidity and valuation multiples?

































